Imaging for early stage breast cancer

Trial

Age

% < 50

50 vs 60

TARGIT

≥ 45

9% No difference

ELIOT

> 48

7% No difference

GEC-ESTRO

≥ 40

14% No difference

Florence University

> 40

16% No difference

NSABPB- 39 RTOG-413

≥ 48

NA No difference

RAPID

≥ 40

NA No difference

IMPORT LOW

≥ 50

NA No difference

IRMA

≥ 49

<2% No difference

SHARE

≥ 50

NA No difference

HUNGARIAN

> 40

20% (30-40 years excluded later in high LR risk)